Fata, SevcanUnsal Avdal, ElifDogan, ErbilÇolak, AysunTokat, MerlindaOkyay, Emre2026-04-252026-04-2520242458-89382564-7288https://doi.org/10.30621/jbachs.1543485https://search.trdizin.gov.tr/tr/yayin/detay/1274290https://hdl.handle.net/11486/7914Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk. Material and Methods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002–2019. The data were obtained from medical records and phone interviews. Univariate and multivariate logistic regression analyses were performed. Results: The incidence of GDM was found to be 16.7%. The regression model indicated that the risk of GDM was 4.57 times higher in the age group 36–40 at conception during the IVF cycle than the age group 31–35 (95% CI = 1.18–17.73, p = .028). Furthermore, women who conceived after the second IVF trial had a risk of GDM 3.464 times higher than those that conceived after their first IVF trial (95% CI = 1.07–11.23, p= .038). Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.eninfo:eu-repo/semantics/openAccessKadın Hastalıkları ve DoğumEndokrinoloji ve MetabolizmaArticle8375075810.30621/jbachs.15434851274290